Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas.

Autor: Zeng, Zhen1 (AUTHOR), Ngo, Hung Long1 (AUTHOR), Proctor, Martina1 (AUTHOR), Rizos, Helen2 (AUTHOR), Dolcetti, Riccardo3 (AUTHOR), Cruz, Jazmina Gonzalez4 (AUTHOR), Wells, James W.4 (AUTHOR), Gabrielli, Brian1 (AUTHOR) briang@uq.edu.au
Zdroj: Pigment Cell & Melanoma Research. Jan2024, Vol. 37 Issue 1, p45-50. 6p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje